Allergic reactions to drugs: Involvement of T cells

Thorax

Volumn 55, Issue SUPPL. 2, 2000, Pages

  Pichler, Werner J ^a   Yawalkar, Nikhil ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA LACTAM ANTIBIOTIC; CYCLOSPORIN A; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PENICILLIN DERIVATIVE; PROCAINAMIDE; SULFAMETHOXAZOLE; SULFONAMIDE; THALIDOMIDE;

ALLERGIC REACTION; ANTIGEN RECOGNITION; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; VIRUS INFECTION;

DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EXANTHEMA; HUMANS; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 0033797665     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. 1 Hoigné R, Schlumberger HU, Vervleot D, et al. Epidemiology of allergic reactions. In: Burr M, ed. Epidemiology of clinical allergy. Epidemiology of allergic reactions to drugs. Monogr Allergy 1993;31:140-170.
2. 2 Bayard PJ, Berger TG, Jacobson MA. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquired Immune Syndromes 1992;5:1237-57.
3. 3 Geyman JP, Erickson S. The ampicillin rash as a diagnostic and management problem: case report and literature review. J Fam Pract 1978;7:493-6.
4. 4 Blanca M, Vega JM, Garcia J, et al. New aspects of allergic reactions to betalactams: cross reactions and unique specificities. Clin Exp Allergy 1994;24:407-15.
5. 5 Gell PG, Coombs RR, eds. The classification of allergic reactions underlying disease. In: Clinical aspects of immunology. Oxford: Blackwell Scientific Publications, 1963: Chapter 13.
6. 6 Katz DH, Benacerraf B. The regulatory influence of activated T cells and B cell responses to antigen. Adv Immunol 1972;15:1-94.
7. 7 Eisen HN, Orris L, Belman S. Elicitation of delayed allergic skin reactions to haptens: The dependence of elicitation on hapten combination with proteins. J Exp Med 1952;95: 473-81.
8. 8 Carr A, Swanson C, Penny R, et al. Clinical and laboratory markers of hypersensitivity to trimethoprimsulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:180-5.
9. 9 Porcelli SA, Morita CT, Modlin RL. T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996;8:510-6.
10. 10 Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995;3:495-507.
11. 11 Beckman EM, Porcelli SA, Morita CT, et al. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994; 372:691-4.
12. 12 Tanaka Y, Morita CT, Tanaka Y, et al. Nature of synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995;375:155-8.
13. 13 Martin S, Weltzien HU. T cell recognition of haptens: a molecular view. Int Arch Allergy Immunol 1994;104:10-6.
14. 14 Weltzien HU, Moulon C, Martin S, et al. T cell immune response to haptens: structural models for allergic and autoimmune reactions. Toxicology 1996;107:141-51.
15. 15 Ortmann B, Martin S, von Bohin A, et al. Synthetic peptides anchor T-cell specific TNP epitopes to MHC antigens. J Immunol 1992;148:1445-50.
16. 16 Köhler J, Hartmann U, Grimm R, et al. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4+ T cells induced by trinitrophenylated peptides. J Immunol 1997;158:591-7.
17. 17 Pichler WJ, Schnyder B, Zanni M, et al. Role of T cells in drug allergies. Allergy 1998;53:225-32.
18. 18 Mauri-Hellweg D, Bettens F, Mauri D, et al. In vitro and in vivo T cell response to drugs in drug allergic individuals. J Immunol 1995;155:462-72.
19. 19 Mauri-Hellweg D, Zanni M, Frei E, et al. Crossreactivity of T cell lines and clones to β-lactam antibiotics. J Immunol 1996;157:1071-9.
20. 20 Zanni MP, Mauri-Hellweg D, Brander Ch, et al. Characterization of lidocaine specific T cells. J Immunol 1997;158: 1139-48.
21. 21 Schnyder B, Mauri-Hellweg D, Zanni MP, et al. Direct MHC dependent presentation of the drug sulfamethoxazole to human αβ T cell clones. J Clin Invest 1997;100:136-41.
22. 22 Zanni MP, von Greyerz S, Schnyder B, et al. HLA restricted, processing and metabolism independent pathway of drug recognition by human αβ+ T lymphocytes. J Clin Invest 1998;102:1591-8.
23. 23 Zanni MP, von Greyerz S, Schnyder B, et al. HLA-unrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Immunol Int 1998;10:507-15.
24. 24 Gerber BO, Zanni MP, Uguccioni M, et al. Functional expression of the eotaxin receptor, CCR3, in T lymphocytes co-localizing with eosinophils. Current Biol 1997; 7:836-43.
25. 25 Pichler WJ, Zanni M, von Greyerz S, et al. High IL-5 production by drug specific T cell clones. Int Arch Appl Allergy Immunol 1997;113:177-80.
26. 26 Schnyder B, Frutig K, Mauri-Hellweg D, et al. T cell mediated cytotoxicity against keratinocytes in sulphamethoxazole induced skin reactions. Clin Exp Allergy 1998;28: 1412-7.
27. 27 Yawalkar N, Egli F, Hari Y, et al. Infiltration of cytotoxic T cells in drug induced cutaneous eruptions. Clin Exp Allergy 2000;30:847-55.